Immunoinhibitors that are targets of immunotherapies and were found here to be associated with VSTM2L in various cancers included CD274, also known as programmed death-ligand 1(PD-L1) (KIRP: r = −.38, p = 6.39E-10; TGCT: r = −.42, p = 2.05E-06); cytotoxic T lymphocyte-associated protein 4(CTLA-4) (TGCT: r = −.43, p = 2.97E-07); and PDCD1, also known as programmed death (PD)-1 (TGCT: r = −.42, p = 6.15E-07; UVM: r = .38, p = .0029). Here, CD274 is linked to cancer.